<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02523261</url>
  </required_header>
  <id_info>
    <org_study_id>MPN_2015_22</org_study_id>
    <nct_id>NCT02523261</nct_id>
  </id_info>
  <brief_title>Interest of Direct Aspiration First Pass Technique (ADAPT) for Thrombectomy Revascularisation of Large Vessel Occlusion in Acute Ischaemic Stroke</brief_title>
  <acronym>ASTER</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mechanical thrombectomy (TM) is now validated through 4 randomized controlled trials of high&#xD;
      scientific level as the reference treatment of cerebral infarction associated with proximal&#xD;
      cerebral occlusion (MR CLEAN, ESCAPE 2014, 2015). These studies have shown for the first time&#xD;
      a major decrease (-35%) of disability related to severe cerebral infarction and reduction in&#xD;
      mortality. These studies only used thrombectomy devices called stent retriever for obtaining&#xD;
      recanalization rates ranging from 58-72% for the 2 largest studies (MR CLEAN, ESCAPE 2014,&#xD;
      2015). This criterion &quot;recanalization&quot; is important because it largely determines the&#xD;
      functional prognosis of patients with severe cerebral infarction (Khatri, 2014).&#xD;
&#xD;
      These results are exciting but we can do even better. Indeed, already new thrombectomy&#xD;
      devices are available with a special interest for ADAPT (A Direct Aspiration First Pass&#xD;
      Technic). This distal suction system, with a high level of endovascular navigability,&#xD;
      provides high recanalization rates (&gt; 90%), low morbidity, with a synergistic effect with&#xD;
      stent retriever (Turk A, Kowoll 2014 and 2015). To date, these technic (ADAPT) has never been&#xD;
      assessed in a randomized controlled trial.&#xD;
&#xD;
      We have previously conducted a comparative observational study between two recanalization&#xD;
      strategies by thrombectomy using first-line ADAPT or the most widely used stent retriever.&#xD;
      The interventional neuroradiologist could, in case of recanalization failure with the&#xD;
      Solitaire system, used another thrombectomy material left to the operator's choice. 244&#xD;
      consecutive patients on two centers (Rothschild Foundation, and Foch Hospital, France)&#xD;
      admitted for a cerebral infarction associated with proximal occlusion were included. This is&#xD;
      so far the largest series of patients with ADAPT system. The complete recanalization rate was&#xD;
      84% with ADAPT versus 68% with stent retriever (P = 0.006). Unpublished data, Oral&#xD;
      presentation at the European Stroke Organization, April 2015). Our research aims to show that&#xD;
      a first line strategy of recanalization by thrombectomy using a distal suction system (ADAPT)&#xD;
      is superior that the use of a stent retriever.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 10, 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete recanalization percentage</measure>
    <time_frame>Immediately after the revascularization procedure is completed</time_frame>
    <description>Proportion of patients in which complete recanalization is achieved as defined by a TICI score equal to 2b or 3</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">381</enrollment>
  <condition>Ischemic Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>ADAPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent Retriever</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>direct aspiration procedure</intervention_name>
    <description>Revascularization by endovascular thrombectomy using the distal aspiration first pass technique</description>
    <arm_group_label>ADAPT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>stent retriever procedure</intervention_name>
    <description>Revascularization by endovascular thrombectomy using a mechanical thrombectomy device</description>
    <arm_group_label>Stent Retriever</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years with no upper age limit.&#xD;
&#xD;
          -  Cerebral infarction in the anterior circulation&#xD;
&#xD;
          -  Occlusion of the anterior circulation proven by CT angiography or MR angiography&#xD;
&#xD;
          -  With or without previous Intravenous thrombolysis&#xD;
&#xD;
          -  Start of thrombectomy procedure within 6 hours of symptoms onset.&#xD;
&#xD;
          -  Patient expresses verbally his non-opposition to be enrolled in the study ; in case&#xD;
             patient cannot communicate, verbal non-opposition is obtained from his close / trusted&#xD;
             person&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absence of indication for thrombectomy&#xD;
&#xD;
          -  Cons-indication for thrombectomy&#xD;
&#xD;
          -  Presence of cerebral infarction of the posterior circulation&#xD;
&#xD;
          -  Occlusion of the cervical carotid artery&#xD;
&#xD;
          -  Allergy to x-ray contrast products&#xD;
&#xD;
          -  Patient was bedridden or using a wheelchair most of the day (pre-event modified Rankin&#xD;
             Scale score &gt; 3) prior to stroke&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Patient under legal protection&#xD;
&#xD;
          -  No affiliation to health insurance&#xD;
&#xD;
        Secondary exclusion criteria&#xD;
&#xD;
        - Lack of access route for catheterization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel PIOTIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation ophtalmologique de Rothschild</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Dupuytren</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Gui de Chaulac</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Neurologique</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Guillaume et René LAENNEC</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>August 12, 2015</study_first_submitted>
  <study_first_submitted_qc>August 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

